Building on years of collaboration, a doctor crosses the San Francisco Bay to continue his work on colorectal cancer prevention with the research team of his mentor.
Kaiser Permanente researchers and colleagues find that non-alcoholic fatty liver disease was less likely to occur in mothers who breastfed for 6 months or more.
The Kaiser Permanente Division of Research has received a T32 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to train young scientists in translating research into practice for people with type 2 diabetes and prediabetes.
"If other health care systems and providers had adopted Kaiser Permanente’s approach and achieved the same rate of decline, I estimated in this latest National Forum report that 40,000 heart disease and stroke deaths in this age group would have been prevented in 2015 alone."
When Sandra Domingue attends her regular fitness class at the Bayview Hunter’s Point YMCA in San Francisco, she’s not thinking about how her time at the gym, which includes both socializing and exercise, could help her live longer.
People who were severely obese and had diabetes had 40 percent fewer heart attacks and strokes — and 67 percent fewer deaths — within 5 years after bariatric weight-loss surgery.
Kaiser Permanente members in Northern California are 52 percent less likely to die from colorectal cancer since the health care system launched a comprehensive, organized screening program, according to a new study in the specialty’s top journal, Gastroenterology.
Marilyn Kwan's research focuses on how wellness factors affect survivorship in breast and bladder cancer patients. Kwan is a certified CrossFit Level 1 trainer; she hopes to some day conduct lifestyle research involving CrossFit in cancer survivors.
The Division of Research's Douglas Corley will be responsible for developing and implementing a new research program in The Permanente Medical Group that will advance the creation of evidence-driven strategies to improve the delivery of health care.
Neurologists of the Kaiser Permanente Northern California Stroke FORCE team get clot-busting alteplase to patients twice as fast as the national average.